Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
01 mars 2021 18h26 HE
|
Achilles Therapeutics
Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States London, UK 1 March 2021 – Achilles Therapeutics plc (“Achilles” or the...
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer
11 nov. 2020 07h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer
11 nov. 2020 02h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer
23 juin 2020 07h00 HE
|
Achilles Therapeutics
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer
23 juin 2020 02h00 HE
|
Achilles Therapeutics
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...
Achilles Therapeutics appoints Carsten Boess to the Board of Directors
07 avr. 2020 07h00 HE
|
Achilles Therapeutics
Achilles Therapeutics appoints Carsten Boess to the Board of Directors Stevenage, UK 7 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell...
Achilles Therapeutics appoints Carsten Boess to the Board of Directors
07 avr. 2020 02h00 HE
|
Achilles Therapeutics
Achilles Therapeutics appoints Carsten Boess to the Board of Directors Stevenage, UK 7 April, 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing personalised cell...
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer
17 mars 2020 08h00 HE
|
Achilles Therapeutics
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer - Professor Quezada is an internationally recognized leader in the field of cancer immunology and a founder of the...
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer
17 mars 2020 03h00 HE
|
Achilles Therapeutics
Achilles Therapeutics appoints Professor Sergio Quezada as Chief Scientific Officer - Professor Quezada is an internationally recognized leader in the field of cancer immunology and a founder of the...
Achilles Therapeutics Appoints Beverley Carr as Chief Business Officer
21 oct. 2019 07h00 HE
|
Achilles Therapeutics
Achilles Therapeutics Appoints Beverley Carr as Chief Business OfficerBrings 20+ years of business development experience Formerly VP, Business Development for the Immuno-inflammation Therapy Area at...